A carregar...
DDIS-10. ENGINEERED EXOSOMES FOR GLIOMA THERAPY
Glioblastoma (GBM) is the most common among all malignant brain tumors, with 17,000 diagnoses every year in the United States. Despite receiving surgery, radiotherapy, and chemotherapy, the median survival of GBM patients is only 14.6 months, and less than 10% of GBM patients survive more than 5 yea...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216546/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.289 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|